Second Affiliated Hospital of Guangzhou Medical University
Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients（Rocket Trial） | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2024-10-22 | NCT06647940 | |
| Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2024-07-03 | NCT06483347 | |
| Interventional Software for Multi-immunotherapy of Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Site, Thoracic Neoplasms, liver cancer, liver disorder, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 / Phase 3 | 2024-06-27 | NCT06478108 | |
| Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors | Solid Tumor, Adult | Recruiting | Phase 1 | 2024-06-26 | NCT06195384 | |
| EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer | EGFR/ B7H3-positive Advanced Lung Cancer; EGFR/ B7H3-positive Advanced Triple-negative Breast Cancer | Recruiting | Early phase 1 | 2024-06-25 | NCT05341492 |